Filtrer vos résultats
- 4
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network studyNeuro-Oncology, 2019, 21 (8), pp.1039-1048. ⟨10.1093/neuonc/noz088⟩
Article dans une revue
hal-02328989v1
|
||
|
Management and outcome of primary CNS lymphoma in the modern era: An LOC network studyNeurology, 2020, 94 (10), pp.e1027-e1039. ⟨10.1212/WNL.0000000000008900⟩
Article dans une revue
hal-02442415v1
|
||
Triage Scoring System Based on Early Post-Transplant Complications for Patients with Myelodysplastic Syndrome Requiring ICU after Allo-HCT: An SFGM-TC StudyBlood, 2016, 128 (22), ⟨10.1182/blood.V128.22.3470.3470⟩
Article dans une revue
hal-03605967v1
|
|||
|
Anti-CD19 CAR T-Cell Therapy for Patients with Richter Syndrome: A Lysa Study from the Descar-T RegistryBlood, 2022, 140 (Supplement 1), pp.3803-3804. ⟨10.1182/blood-2022-158807⟩
Article dans une revue
hal-04020852v1
|